This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Boehringer Ingelheim Rcv Gmbh & Co. Kg. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Jochen Urthaler: Innovator in Biomolecule Production
Introduction
Jochen Urthaler is a notable inventor based in Maria Enzersdorf, Austria. He has made significant contributions to the field of biomolecule production, particularly in developing scalable processes for producing pharmaceutical-grade plasmid DNA. His innovative approach has the potential to enhance the efficiency and automation of biomolecule manufacturing.
Latest Patents
Jochen Urthaler holds 1 patent for his invention titled "Methods and devices for producing biomolecules." This patent describes a scalable process and device designed for producing biomolecules, specifically focusing on pharmaceutical-grade plasmid DNA. The process involves alkaline lysis and neutralization steps, allowing for the effective separation of lysate and precipitate. The mixture flows through a clarification reactor filled with retention material, such as glass beads, which retains the precipitate. The lysis step is optimized by using a lysis reactor filled with particulate material, enabling continuous and fully automated operation.
Career Highlights
Jochen Urthaler is currently associated with Boehringer Ingelheim RCV GmbH & Co. KG, where he applies his expertise in biomolecule production. His work at this esteemed company highlights his commitment to advancing pharmaceutical manufacturing processes.
Collaborations
Throughout his career, Jochen has collaborated with talented professionals, including Roman Necina and Christine Ascher. These collaborations have contributed to the development and refinement of innovative processes in the field.
Conclusion
Jochen Urthaler's contributions to biomolecule production exemplify the impact of innovation in the pharmaceutical industry. His patented methods and devices pave the way for more efficient and automated production processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile